Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Etanercept in Plaque Psoriasis After Adalimumab Failure
NCT01543204Phase 4Terminated
- Sponsor
- Amgen
- Start
- Feb 2012
- Primary completion
- May 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Amgen. Started Feb 2012; status: terminated.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01543204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01543204.